Calendar
Top-down
A look at earnings from the view of macro-economists and market technicians
Market Overview
Heat Map
Sentiment
Technicals
Retail Sales
Pricing
Manu-facturing
Economic Cycle
Bottom-up
A bottom-up view of earnings from professional equity analysts
Earnings Highlights
Date Trades
Earnings News
Pivots
Earnings Cycle
Sector Analysis
Investor
Trader
Support
Documentation, research, and support for the information provided
Indicators
Results
About Us
Library
Contact Us
Plays
Score
Grade
Sign In
Sign In
or
Register
Forgot Password?
OR
Sign in using:
Don't have an account?
Register
QGEN
$54.16
Qiagen N.V.
QGEN
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus: $0.66
Revenue: $517.00 Mil
Wednesday
Nov 4
After the close
Score
Grade
Tweet
Share
Watch
Sentiment
Analysts
Sentiment
Analysts
Tweet
Share
Watch
Latest EPS
Tuesday, October 27, 2020
QIAGEN Reports Strong Results for Third Quarter and First Nine Months of 2020 and Increases Outlook for Full-Year 2020
What do you expect when QGEN reports earnings?
Beat
Meet
Miss
Where is QGEN's stock price going from here?
Up
Flat
Down
Analysts
Score
Grade
Sentiment
Analysts
Pivots
Resistance
$55.27
$54.95
$54.56
$54.24
Support
$53.85
$53.53
$53.14
Tweet
Trends
Short-term Price
Intermediate-term Price
Long-term Price
Investors' Sentiment
Analysts' Sentiment
Earnings Estimates
Growth
Description
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Peers
Biogen
Amgen
Gilead Sciences
Neurocrine Biosciences
Bluebird Bio
Seattle Genetics
Sangamo Therapeutics
Repligen
BioCryst Pharmaceuticals
Novavax
Expectations
›
Qiagen N.V.
